These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 2895455)
21. Adverse reactions to H2-receptor antagonists in Denmark before and after transfer of cimetidine and ranitidine to over-the-counter status. Andersen M; Schou JS Pharmacol Toxicol; 1991 Oct; 69(4):253-8. PubMed ID: 1683484 [TBL] [Abstract][Full Text] [Related]
22. Effect of cimetidine and ranitidine on cardiovascular drugs. Baciewicz AM; Baciewicz FA Am Heart J; 1989 Jul; 118(1):144-54. PubMed ID: 2662728 [TBL] [Abstract][Full Text] [Related]
23. Histamine H2-antagonist drug interactions in perspective: mechanistic concepts and clinical implications. Powell JR; Donn KH Am J Med; 1984 Nov; 77(5B):57-84. PubMed ID: 6150639 [TBL] [Abstract][Full Text] [Related]
24. Interactions and non-interactions with ranitidine. Kirch W; Hoensch H; Janisch HD Clin Pharmacokinet; 1984; 9(6):493-510. PubMed ID: 6096071 [TBL] [Abstract][Full Text] [Related]
25. Ranitidine versus cimetidine. A comparison of their potential to cause clinically important drug interactions. Smith SR; Kendall MJ Clin Pharmacokinet; 1988 Jul; 15(1):44-56. PubMed ID: 3042245 [TBL] [Abstract][Full Text] [Related]
26. Use of i.v. cimetidine, ranitidine, and famotidine in 40 hospitals. Segal R; Russell WL; Oh T; Ben-Joseph R Am J Hosp Pharm; 1993 Oct; 50(10):2077-81. PubMed ID: 8238052 [TBL] [Abstract][Full Text] [Related]
28. Effects of cimetidine and ranitidine on hepatic drug metabolism. Breen KJ; Bury R; Desmond PV; Mashford ML; Morphett B; Westwood B; Shaw RG Clin Pharmacol Ther; 1982 Mar; 31(3):297-300. PubMed ID: 6120774 [TBL] [Abstract][Full Text] [Related]
29. Effect of H2 antagonists on the differential secretion of triamterene and its sulfate conjugate metabolite by the isolated perfused rat kidney. Muirhead MR; Somogyi AA Drug Metab Dispos; 1991; 19(2):312-6. PubMed ID: 1676629 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease. Hatlebakk JG; Berstad A Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586 [TBL] [Abstract][Full Text] [Related]